SCHEMBL6002839

SCHEMBL6002839

CC/C=C/C[CH]c1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.44
KCNH2 Q12809 2/20 0.38
MAOB P27338 2/20 0.35
AHR P35869 1/20 0.35
LMNA P02545 1/20 0.35
CYP2A6 P11509 1/20 0.35
PTGER4 P35408 1/20 0.34
TACR2 P21452 1/20 0.34
PTGS1 P23219 2/20 0.33
TRPA1 O75762 1/20 0.33
ALOX5 P09917 1/20 0.33
PTGS2 P35354 1/20 0.33
CYP1A2 P05177 1/20 0.33
AKR1C3 P42330 1/20 0.33
AKR1C1 Q04828 1/20 0.33
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1609713 0.84 HSD17B10 (0.55) HSD17B10KCNH2MAOBAHRLMNA
SCHEMBL9784248 0.77 ALDH1A1 (0.40) MAOBCYP2A6MEN1MAPTKMT2A
SCHEMBL9491843 0.77 ALDH1A1 (0.40) MAOBCYP2A6MEN1MAPTKMT2A
SCHEMBL5682112 0.77 HSD17B10 (0.48) HSD17B10KCNH2MAOBAHRLMNA
SCHEMBL257322 0.77 KCNH2 (0.51) HSD17B10KCNH2MAOBAHRPTGS1
SCHEMBL8170937 0.77 KCNH2 (0.51) HSD17B10KCNH2MAOBAHRPTGS1
SCHEMBL293565 0.73 HSD17B10 (0.48) HSD17B10KCNH2MAOBAHRLMNA
SCHEMBL27645313 0.71 KCNH2 (0.53) KCNH2MAOBLMNACYP2A6
SCHEMBL8116628 0.70 KCNH2 (0.45) HSD17B10KCNH2
SCHEMBL2186171 0.69 ALDH1A1 (0.42) HSD17B10LMNACYP2A6MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed